Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Naloxone
(Synonym: D01340)		[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 226
2NALOXONE HYDROCHLORIDE
(Synonym: D01340)		[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
3NALOXONE HYDROCHLORIDE DIHYDRATE
(Synonym: D01340)		[1] Naloxone[2] D01340 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
4Oxycodone naloxone prolonged release tablets
(Synonym: D01340)		[2] Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
5Oxycodone/naloxone prolonged release t
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
6Oxycodone/Naloxone Prolonged Release tablets
(Synonym: D01340)		[2] Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
7Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
8Oxycodone/naloxone prolonged release tablets 10/5 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
9Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
10Oxycodone/naloxone prolonged release tablets 20/10 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
11Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
12Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(Synonym: D01340)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226